Innovent Biologics


Innovent Biologics, Inc. is a China-based biopharmaceutical company. The Company's main products include PD-1 antibody; bevacizumab (Avastin) biosimilar, IBI-305; rituximab (MabThera/Rituxan) biosimilar, IBI-301; and adalimumab (Humira) biosimilar, IBI-303.

Industries

Headquarters

Suzhou, China

Employees

1,001-5,000

Links


Org chart

Yu Dechao
Founder, Chairman & CEO
Collapse
Liu Yongjun
President
Gao Changshou
Chief Technology Officer & SVP
Xi Hao
Executive Director & CFO
Zhang Qian
Chief Talent Officer
Yong Jun Liu
President
Guoqiang Hu
Senior Vice President
Kenneth Kang
Suzhou M1 General Manager, Senior VP
Samuel Zhang
Chief Business Officer

Board & advisors

Chen Kaixian
Independent Non-executive Director
Xu Yiyin
Independent Non-executive Director
Charles L. Cooney
Independent Non-Executive Director
Gary Zieziula
Independent Non-executive Director